CPT code 86707: Hepatitis B antibody, anti-HBe2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Measures antibody to hepatitis B e antigen to help assess viral phase and monitor hepatitis B infection alongside other serologic and molecular markers.
Medicare pays $11.57 for 86707 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$11.57
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 86707 covers
This laboratory test measures antibody to the hepatitis B e antigen, commonly called anti-HBe. Clinicians use the result in hepatitis B assessment and monitoring, including evaluation of changes in viral activity. It is commonly interpreted with hepatitis B e antigen testing and other hepatitis B markers; the result alone does not establish the degree of viral replication.
Report 86707 for the anti-HBe assay performed. Medicare pays it through the Clinical Laboratory Fee Schedule (CLFS), not the physician fee schedule. The 2026 national CLFS amount is $11.57, unchanged since 2020. One amount applies in every state and locality, with no geographic or office/facility adjustment. The test is excluded from the physician fee schedule by statute.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 86707
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 86707. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 86707 with status X (excluded by statute), so the test itself is paid only from the CLFS.
86707 on the lab fee schedule since 2020
86707 · CLFS 2026 Q4 (current)
$11.57
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
86707 compared with similar tests
- 87350HBeAg testImmunoassay antigen detection$11.53
- 86707 measures antibody to hepatitis B e antigen; 87350 measures the e antigen itself.
- 86706Surface antibodyHepatitis B$10.74
- 86706 measures antibody to hepatitis B surface antigen, not e antigen.
- 86704Core antibodyTotal antibody$12.05
- 86704 measures total antibody to hepatitis B core antigen, a different viral marker from anti-HBe.
- 86705Hepatitis B core antibodyIgM antibody$11.77
- 86705 measures IgM antibody to hepatitis B core antigen; 86707 measures antibody to hepatitis B e antigen.
86707 billing questions
How is 86707 different from the hepatitis B e antigen test?
86707 measures antibody to the e antigen. The e antigen test, 87350, measures the antigen itself; clinicians may interpret both results together.
Are 86704 and 86706 interchangeable with 86707?
No. Code 86704 measures total hepatitis B core antibody and 86706 measures surface antibody; neither measures anti-HBe.
What does a positive anti-HBe result mean?
It indicates antibody to hepatitis B e antigen and may inform assessment of a change in viral phase. Interpret it with other hepatitis B results and the clinical picture.
What test should be reported with 86707?
Report 86707 for the anti-HBe assay performed. It identifies a different hepatitis B marker from core or surface antibody tests.
How does Medicare pay for 86707?
Medicare pays the test through the CLFS. The national amount is the same across localities and office and facility settings.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 86707 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist